Aroma Inhalation and Exam Stress: Role of Emotional Intelligence and Stress Biomarkers

November 2, 2026 updated by: Gulbahar Boyuk Ozcan

Effect of Aroma Inhalations (Thyme and Juniper) on Exam Stress and Apelin and Cerebral (BDNF) Stress Response (GRP78) According to Emotional Intelligence Levels and Stress Management Skills

This study is an interventional investigation aiming to evaluate the physiological effects of thyme (Thymus vulgaris) and juniper (Juniperus communis) essential oil aroma inhalation on examination stress in medical students. The research assesses participants' emotional intelligence and exam anxiety levels, and analyzes changes in salivary apelin, BDNF, and GRP78 levels using the ELISA method before and after the aromatherapy intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study Purpose: This study aims to investigate the effects of aroma inhalations (thyme and juniper) on exam stress, adipokines (apelin), neurotrophic factors (BDNF), and endoplasmic reticulum stress responses (GRP78) based on emotional intelligence and exam anxiety levels in medical students. Methods: The study is a three-arm, randomized, controlled interventional investigation conducted on healthy volunteer medical students. Saliva samples are collected before inhalation and immediately after the 15-minute intervention. The ELISA technique is utilized to determine salivary apelin, BDNF, and GRP78 levels.

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altindag
      • Ankara, Altindag, Turkey (Türkiye), 06050
        • Ankara Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Being willing to participate in the research, being a medical student, not having a cardiovascular disease, not having any allergies to odors, not being pregnant, not having any respiratory system diseases (such as asthma, COPD, etc.), not having any condition that prevents smelling, not using any medication that affects heart rate and blood pressure, and not having any psychiatric illness.

Exclusion Criteria:

The communication barrier, incomplete filling of forms, menstruation in girls, allergy to the scents of thyme and juniper oil, and the occurrence of any side effects during the application.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Juniper Aromatherapy Group

Participants inhale juniper essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation.

Participants inhale juniper essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters.

Experimental: Thyme Aromatherapy Group

Participants inhale thyme essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation.

Participants inhale thyme essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Salivary Apelin Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention

Salivary apelin levels will be measured to evaluate the metabolic and neuroendocrine response to aroma inhalation.

Immediately before inhalation and immediately after the 15-minute inhalation intervention
Change in Salivary BDNF Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention

Salivary BDNF levels will be measured as a neurotrophic and physiological stress indicator.

Immediately before inhalation and immediately after the 15-minute inhalation intervention
Change in Salivary GRP78 Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention

Salivary GRP78 levels will be measured to monitor cellular endoplasmic reticulum stress responses.

Immediately before inhalation and immediately after the 15-minute inhalation intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

July 9, 2025

First Submitted That Met QC Criteria

November 2, 2026

First Posted (Actual)

November 6, 2026

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AROMA-MED-2025-02
  • E-81477236-604.01.01-3006 (Other Identifier: Ethics Committee Approval Number, Ankara Medipol University Faculty of Medicine, Turkey)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual participant data (IPD) will not be shared due to ethical considerations and institutional restrictions.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.